NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Disparities in the Proportion of Ticagrelor and Prasugrel-eligible Patients with Acute Coronary Syndrome in a Real-world Registry

NCT05774431

CompletedN/A

Sponsor: University Hospital Heidelberg

Conditions: Acute Myocardial Infarction

Interventions: There was no intervention necessary.

Countries: Germany

The primary objective of this study is to compare patients eligible for ASS and Ticagrelor against those eligible for ASS and Prasugrel. The available information regarding relative and absolute exclusion criteria outlines reasons for disqualification from either drug. The secondary objectives of the study are to: * Assess the proportion of patients who received ASS and Ticagrelor in the study cohort. * Compare the proportion of patients who received ASS and Ticagrelor against the proportion of patients who qualify for DAPT with ASS and Ticagrelor (eligible group). * Describe the antithrombotic treatment, including antiplatelet monotherapies, and antiplatelet therapies with or without anticoagulation. The investigators will use these objectives to evaluate the effectiveness and appropriateness of the different antiplatelet therapies in the study population. Participants will not be personally identified in any reports or publications resulting from this study.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients over 18 years old
* Clinical symptoms of acute coronary syndrome

Exclusion Criteria:

* hemodialysis
* Atrial tachycardia with accompanying symptoms, but without clinical suspicion of an ACS (Acute Coronary Syndrome).

Locations (1)

Heidelberg, Baden-Wurttemberg, Germany